Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous skin-derived adult keratinocytes expanded
- Development stage
- Unknown
- Lead developer
- Red Andaluza de Terapias Avanzadas
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
This autologous cell therapy consists of keratinocytes harvested from a patient's own skin, expanded ex vivo in a laboratory setting, and subsequently transplanted back onto the patient. Developed by the Red Andaluza de Diseño y Traslación de Terapias Avanzadas (Fundación Pública Andaluza Progreso y Salud), it is primarily indicated for the reconstruction of skin defects following Mohs micrographic surgery for basal cell carcinoma. The therapy functions by providing a high density of viable, proliferative keratinocytes directly to the surgical site, thereby accelerating re-epithelialization, promoting wound healing, and potentially improving cosmetic and functional outcomes compared to traditional healing methods such as secondary intention or skin grafting.
- Other names
- autologous expanded keratinocytesautologous keratinocytesautologous skin-derived adult keratinocytes expanded
Beyond the preview
Go deeper on autologous skin-derived adult keratinocytes expanded.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous skin-derived adult keratinocytes expanded.